This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

IND

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What IND Means in Everyday Medical Language

IND stands for Investigational New Drug. It refers to a medicine that has been tested in laboratories and animals and has received approval from the U.S. Food and Drug Administration (FDA) to be tested in people. These drugs are often called experimental or investigational drugs because they are still being studied to understand how well they work and how safe they are. An IND may be approved by the FDA for testing in one disease but still considered investigational for others.

Why IND Can Matter in Cancer Care

In cancer care, INDs represent new treatment options that are not yet widely available. They may offer hope for patients whose cancer has not responded to standard treatments. Access to INDs is usually through clinical trials, which help researchers learn if the drug is safe and effective. Sometimes, patients who cannot join trials may get access through special programs like expanded access or right to try. However, because these drugs are still being studied, they may have unknown serious side effects. Understanding what IND means can help patients and caregivers make informed decisions about treatment options.

Where Patients Might See or Hear the Term IND

The term IND may appear in medical records, treatment plans, clinical trial information, or drug information pages. It might be mentioned when discussing new or experimental treatments being considered or offered. Because the term can be confusing, it’s important to ask your care team exactly how it applies to your situation rather than assuming it means a diagnosis or a recommended treatment.

Common Confusions and What IND Does Not Automatically Mean

Seeing IND does not mean you have been diagnosed with a new disease or that you must take an experimental drug. It simply means a drug is being studied and may be available through research or special programs. IND is not a treatment recommendation by itself. Also, the term can appear under different names like experimental drug or investigational agent, which all refer to the same concept. Comparing the wording in your reports or sources can help avoid confusion.

Practical Questions to Ask Your Care Team

If you encounter the term IND, you might ask: What does this drug or treatment mean for my care? Is this drug part of a clinical trial or another program? What are the potential benefits and risks? Are there other standard treatments available? How will my safety be monitored if I take this drug? Understanding these points can help you make informed choices.

How to Read the Term IND in Context

IND should always be read in the context of your specific medical situation. It is not a diagnosis or a guaranteed treatment option. Instead, it signals that a drug is still under study and may be available through research or special access programs. Your care team can explain how IND relates to your treatment plan and what steps you might consider next.

Safety and Next Steps

This information is educational and does not decide what is safe or appropriate for any individual. If IND appears in your medical records or discussions, the best next step is to ask your care team for a clear explanation about what it means for you. They can help you understand your options, including clinical trials or other ways to access investigational drugs, and support you in making decisions that fit your needs and preferences.

Sources

Public source information used for this glossary entry includes: